Drug-to-Drug Interactions May Interfere with COVID-19 Treatments

December 8, 2020

Throughout the COVID-19 pandemic, the Food and Drug Administration (FDA) has granted emergency use authorization (EUA) of several drugs to treat patients ill with the coronavirus. Raising awareness of possible interactions between these newly authorized medications for treating COVID-19 and the patient’s current drug regimen for other health issues is important for optimal care.

Older patients and those with pre-existing health conditions may be taking multiple medications that can, as you know, increase the risk of a drug-to-drug interaction.

The FDA has posted information online for physicians and patients about all of the medications granted emergency authorization for treating COVID-19.

For more information on how to reduce the risk of medication errors and keep patients safe, review ISMIE’s resource on medication management. In short, appropriate management of a patient’s medication boils down to communication, documentation and having good systems in place.

If you have questions, please contact our Risk Management team by email.
Share this article:

Cookie Consent

Cookies are required for some functionality on our site. View our privacy policy for more information.